Equities

SpectraCure AB (publ)

SpectraCure AB (publ)

Actions
  • Price (EUR)0.0709
  • Today's Change-0.003 / -3.93%
  • Shares traded0.00
  • 1 Year change-75.80%
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024 07:06 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of SEK
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments5793130
Total Receivables, Net1.020.740.69
Total Inventory------
Prepaid expenses0.780.430.41
Other current assets, total------
Total current assets5994131
Property, plant & equipment, net6.953.966.18
Goodwill, net------
Intangibles, net786354
Long term investments0.691.23--
Note receivable - long term------
Other long term assets------
Total assets145162191
LIABILITIES
Accounts payable1.041.611.83
Accrued expenses6.907.147.29
Notes payable/short-term debt000
Current portion long-term debt/capital leases2.322.432.41
Other current liabilities, total0.330.680.82
Total current liabilities111212
Total long term debt4.400.272.49
Total debt6.722.704.90
Deferred income tax------
Minority interest------
Other liabilities, total------
Total liabilities151215
SHAREHOLDERS EQUITY
Common stock9.719.719.71
Additional paid-in capital258258258
Retained earnings (accumulated deficit)(138)(117)(92)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total--0.00--
Total equity130150176
Total liabilities & shareholders' equity145162191
Total common shares outstanding979797
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.